Related Experiment Video
Updated: Nov 19, 2025
10:04
Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
19.0K
COVID-19 and active primary tuberculosis in a low-resource setting: A case report
Muhammad Anis Baskara1, Firdian Makrufardi2, Ardiana Dinisari3
1House Officer of Prambanan General Hospital, Yogyakarta, Indonesia.
Annals of Medicine and Surgery (2012)
|January 28, 2021
Summary
This case report highlights the challenges of diagnosing COVID-19 in a low-resource setting, particularly when co-infected with active tuberculosis. Further research is crucial for effective management strategies.
Area of Science:
- Infectious Diseases
- Public Health
- Clinical Medicine
Background:
- Limited studies explore clinical features of COVID-19 patients with active tuberculosis.
- Distinguishing COVID-19 from other respiratory illnesses is challenging in low-resource settings.
- Co-infection of COVID-19 and tuberculosis presents unique management difficulties.
Observation:
- A 42-year-old diabetic male presented with symptoms mimicking both tuberculosis and COVID-19.
- Initial tests detected Mycobacterium Tuberculosis Bacteria (MTB) but were negative for COVID-19.
- Nasopharyngeal and oropharyngeal swabs confirmed a COVID-19 diagnosis on the second day.
Findings:
- The case underscores the diagnostic complexities of concurrent COVID-19 and active tuberculosis.
- The patient required isolation for tuberculosis while awaiting COVID-19 confirmation.
- Lack of specific treatment guidelines for this co-infection complicates patient care.
Implications:
- Low-resource settings face significant hurdles in managing COVID-19 and tuberculosis co-infections.
- Accessible ventilation support and intensive care are critical but often unavailable.
- Further studies are essential to define clinical characteristics, diagnosis, and management protocols.
Related Concept Videos
01:29Pulmonary Tuberculosis I
507
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
507
01:28Pulmonary Tuberculosis V
323
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
323
01:28Pulmonary Tuberculosis II
887
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
887
01:31Pulmonary Tuberculosis III
606
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
606
01:26Pulmonary Tuberculosis IV
286
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
286
01:22Chronic Obstructive Pulmonary Disease
1.9K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.9K